Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199391 · ClinicalTrials.gov registry record · NA
BioWick SureLock Clinical Outcomes Study
A NA study of Rotator Cuff Tear, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 7
- Study locations
NCT03199391 is a NA study of Rotator Cuff Tear that has completed, run by Zimmer Biomet. The registered enrollment target is 71 participants, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (18% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT03199391, a NA study of Rotator Cuff Tear, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to collect postmarket data in subjects who receive surgical treatment of a full-thickness rotator cuff tear (of at least 1.5 cm) with the BioWick™ SureLock™ implant. Both performance and safety data will be collected.
Conditions Studied
Interventions
- DEVICE BioWick SureLock Implant
Study Locations (7)
Florida
- Orthopaedic Medical Group of Tampa Bay PA - Brandon
- Foundation for Orthopaedic Research and Eduation - Temple Terrace
Arizona
- The Orthopaedic Clinic Association - Phoenix
California
- Eisenhower Medical Center - Rancho Mirage
Kentucky
- Norton Orthopaedics and Sports Medicine - Louisville
Utah
- University of Utah - Salt Lake City
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2021-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03199391
The ClinicalTrials.gov registry entry for NCT03199391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (18% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 1 intervention - of which BioWick SureLock Implant is the first listed.
NCT03199391 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT03199391 about?
NCT03199391 is a clinical study titled "BioWick SureLock Clinical Outcomes Study". The purpose of this study is to collect postmarket data in subjects who receive surgical treatment of a full-thickness rotator cuff tear (of at least 1.5 cm) with the BioWick™ SureLock™ implant. Both performance and safety data will be collected.
What is the current status of trial NCT03199391?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2017-04-26. Estimated completion is 2021-05-05.
What conditions does trial NCT03199391 study?
This clinical trial studies the following conditions: Rotator Cuff Tear.
What interventions are being tested in trial NCT03199391?
The interventions under investigation include: BioWick SureLock Implant (DEVICE).
Who is sponsoring clinical trial NCT03199391?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03199391 being conducted?
This trial has 7 study locations across Arizona, California, Florida, Kentucky, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
Oxandrolone Rotator Cuff Trial
ACTIVE NOT RECRUITING · NA
-
Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
ACTIVE NOT RECRUITING · NA
-
Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears
COMPLETED · NA
-
Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot
COMPLETED · NA
-
Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.